| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085558747 |
| P356 | DOI | 10.1186/S12885-017-3328-Z |
| P932 | PMC publication ID | 5441096 |
| P698 | PubMed publication ID | 28532404 |
| P50 | author | Agus Darwanto | Q96204876 |
| P2093 | author name string | Yi Kong | |
| Eric Lader | |||
| Simon Hughes | |||
| Danielle Adams | |||
| Dirk Zimmermann | |||
| Nishit Patel | |||
| Sascha Strauss | |||
| Andreas Kühne | |||
| Dan Shiffman | |||
| Andrew Sheridan | |||
| Anne-Mette Hein | |||
| Austin Ricker | |||
| Dan Richards | |||
| Kai Te Kaat | |||
| Monika Ngowe | |||
| Thomas Rothmann | |||
| Timothy Pelletier | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. | Q27851422 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation | Q28075719 | ||
| Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides | Q28731283 | ||
| Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls | Q30758000 | ||
| The next generation becomes the now generation | Q33553470 | ||
| KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice | Q33759960 | ||
| Archived formalin-fixed paraffin-embedded (FFPE) blocks: A valuable underexploited resource for extraction of DNA, RNA, and protein | Q33828330 | ||
| Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes | Q34356721 | ||
| Combining Highly Multiplexed PCR with Semiconductor-Based Sequencing for Rapid Cancer Genotyping | Q34527216 | ||
| Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis | Q34659939 | ||
| Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis | Q34903217 | ||
| Detection of tropical fungi in formalin-fixed, paraffin-embedded tissue: still an indication for microscopy in times of sequence-based diagnosis? | Q35563424 | ||
| Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samples. | Q35641264 | ||
| Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers | Q35772123 | ||
| Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase | Q36071877 | ||
| Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients | Q36085452 | ||
| Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. | Q36472281 | ||
| Factors in tissue handling and processing that impact RNA obtained from formalin-fixed, paraffin-embedded tissue | Q36942504 | ||
| Biomarker testing for treatment of metastatic colorectal cancer: role of the pathologist in community practice | Q38223785 | ||
| Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array | Q38296380 | ||
| High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing. | Q38392770 | ||
| Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies | Q38649740 | ||
| Influence of parasite density and sample storage time on the reliability of Entamoeba histolytica-specific PCR from formalin-fixed and paraffin-embedded tissues | Q39012318 | ||
| Comparison of Five Commercial Nucleic Acid Extraction Kits for the PCR-based Detection of Burkholderia Pseudomallei DNA in Formalin-Fixed, Paraffin-Embedded Tissues | Q39315799 | ||
| Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. | Q39476678 | ||
| Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma | Q40314201 | ||
| Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer | Q43136720 | ||
| Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration | Q52915844 | ||
| Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology | Q87890762 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 358 | |
| P577 | publication date | 2017-05-22 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform | |
| P478 | volume | 17 |
| Q54996932 | A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? |
| Q94475383 | Multidisciplinary treatment of soft tissue sarcomas: An update |
| Q47107418 | Next-generation sequencing: recent applications to the analysis of colorectal cancer. |
| Q88330764 | Pre-clinical validation of a next generation sequencing testing panel |
| Q57292754 | Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis |
| Q51760971 | Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients. |
Search more.